Corporate Corruption News Articles

Excerpts of key news articles on

Below are key excerpts of revealing news articles on corporate corruption from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

Note: Explore our full index to revealing excerpts of key major media news articles on dozens of engaging topics. And read excerpts from 20 of the most revealing news articles ever published.

Sperm counts have been dropping; infant boys are developing more genital abnormalities; more girls are experiencing early puberty; and adult women appear to be suffering declining egg quality and more miscarriages. It's not just humans. Scientists report genital anomalies in a range of species, including unusually small penises in alligators, otters and minks. In some areas, significant numbers of fish, frogs and turtles have exhibited both male and female organs. Experts say the problem is a class of chemicals called endocrine disruptors, which mimic the body's hormones and thus fool our cells. This is a particular problem for fetuses as they sexually differentiate early in pregnancy. Endocrine disruptors can wreak reproductive havoc. These endocrine disruptors are everywhere: plastics, shampoos, cosmetics, cushions, pesticides, canned foods and A.T.M. receipts. They often aren't on labels and can be difficult to avoid. Chemical companies ... lobby against even safety testing of endocrine disruptors, so that we have little idea if products we use each day are damaging our bodies or our children. Still, the Endocrine Society, the Pediatric Endocrine Society, the President's Cancer Panel and the World Health Organization have all warned about endocrine disruptors, and Europe and Canada have moved to regulate them. But in the United States, Congress and the Trump administration seemed to listen more to industry lobbyists than to independent scientists.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and health from reliable major media sources.

Big corporations accused of driving environmental and health inequalities in black and brown communities through toxic and climate-changing pollution are also funding powerful police groups in major US cities, according to a new investigation. Some of America’s largest oil and gas companies, private utilities, and financial institutions that bankroll fossil fuels also back police foundations – opaque private entities that raise money to pay for training, weapons, equipment, and surveillance technology for departments across the US. The investigation by the Public Accountability Initiative, a nonprofit corporate and government accountability research institute ... details how police foundations in cities such as Seattle, Chicago, Washington, New Orleans and Salt Lake City are partially funded by household names such as Chevron, Shell and Wells Fargo. Police foundations are industry groups that provide substantial funds to local departments, yet, as nonprofits, avoid much public scrutiny. The investigation details how firms linked to fossil fuels also sponsor events and galas that celebrate the police, while some have senior staff serving as directors of police foundations. The report portrays the fossil fuel industry as a common enemy in the struggle for racial and environmental justice. “Many powerful companies that drive environmental injustice are also backers of the same police departments that tyrannize the very communities these corporate actors pollute,” it states.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corruption in policing and in the corporate world from reliable major media sources.

Apple contractors regularly hear confidential medical information, drug deals, and recordings of couples having sex, as part of their job providing quality control, or “grading”, the company’s Siri voice assistant. Although Apple does not explicitly disclose it in its consumer-facing privacy documentation, a small proportion of Siri recordings are passed on to contractors working for the company around the world. Apple says the data “is used to help Siri and dictation ... understand you better and recognise what you say”. But the company does not explicitly state that that work is undertaken by humans who listen to the pseudonymised recordings. A whistleblower working for the firm, who asked to remain anonymous due to fears over their job, expressed concerns about this lack of disclosure, particularly given the frequency with which accidental activations pick up extremely sensitive personal information. The whistleblower said: “There have been countless instances of recordings featuring private discussions. These recordings are accompanied by user data showing location, contact details, and app data.” Although Siri is included on most Apple devices, the contractor highlighted the Apple Watch and the company’s HomePod smart speaker as the most frequent sources of mistaken recordings. As well as the discomfort they felt listening to such private information, the contractor said they were motivated to go public about their job because of their fears that such information could be misused.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the disappearance of privacy from reliable major media sources.

U.S. Senator Bernie Sanders plans to send a letter to Catalyst Pharmaceuticals on Monday asking it to justify its decision to charge $375,000 annually for a medication that for years has been available to patients for free. The drug, Firdapse, is used to treat Lambert-Eaton Myasthenic Syndrome (LEMS), a rare neuromuscular disorder. The disorder affects about one in 100,000 people in the United States. The government is intensifying its scrutiny of the pharmaceutical industry and rising prescription drug prices. Both the Democratic-led U.S. House of Representatives and the Senate, controlled by Republicans, have begun holding hearings this year on the rising costs of medicines. In the letter dated Feb. 4, Sanders asked Catalyst to lay out the financial and non-financial factors that led the company to set the list price at $375,000, and say how many patients would suffer or die as a result of the price and how much it was paying to purchase or produce the drug. For years, patients have been able to get Firdapse for free ... through a U.S. Food and Drug Administration (FDA) program called "compassionate use." The program allows patients with rare diseases and conditions access to experimental drugs outside of a clinical trial when there is no viable alternative. Florida-based Catalyst received FDA approval of Firdapse in November, along with exclusive rights to market the medication for several years. In December, Catalyst announced it would price Firdapse at $375,000 a year.

Note: Read how a major drug price increase nearly bankrupted the city of Rockford, Illinois. For more along these lines, see concise summaries of deeply revealing Big Pharma corruption news articles from reliable major media sources.

People who work at the U.S. Food and Drug Administration (FDA) as medical reviewers are responsible for parsing the risks and benefits of a particular drug before it gets the agency's approval. But a new report from two researchers at the Oregon Health and Science University, published in the journal The BMJ, suggests many of these medical reviewers go on to work for the drug companies they oversaw while working for the government. The study's authors ... looked at the FDA's list of haematology-oncology drug approvals from 2006 to 2010 and scanned all medical reviews from 2001 to 2010 in the agency's database, then looked up the subsequent jobs of the people who worked as medical reviewers for those drug approvals. The researchers found that among 55 people who worked as haematology-oncology medical reviewers from 2001 to 2010, 27 continued in their roles at the FDA, two people worked at the FDA but held other appointments, and 15 left the FDA to work with or consult for the biopharmaceutical industry. "If you know in the back of your mind that a major career opportunity after the FDA is going to work on the other side of the table, I worry it can make you less likely to put your foot down," says study author Dr. Vinay Prasad. "Regulators may be less willing to be very tough, and I worry that is happening." Prasad says he would like to see more transparency from the FDA on the number of people who go from the agency to the drug industry.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corruption in government and in Big Pharma from reliable major media sources.

The American Heart Association and the American College of Cardiology released new guidelines for prescribing cholesterol-lowering medicines. The big winners are expected to be the drug makers that sell statins, since other types of pills were not recommended. Of the 15 panelists that authored these new guidelines, six reported having recent or current ties to drugmakers that already sell or are developing cholesterol medications. And among the half dozen who disclosed these relationships was one of the two panel co-chairs, which contradicts an Institute of Medicine suggestion about managing conflicts and leadership roles on such panels. To be specific, the Institute of Medicine wrote that, “whenever possible, guideline development group members should not have conflicts of interest ... and the chair or co-chairs should not be a person(s) with conflicts of interest.” The Institute of Medicine also wrote that members with conflicts should not represent a majority (here is the IOM report). “One of the reasons the IOM recently recommended eliminating rather than ‘managing’ financial conflicts of interest in guideline development groups is because of concerns about implicit bias,” says Lisa Cosgrove ... at the University of Massachusetts. “When individuals have commercial ties they are vulnerable to developing subtle, but sometimes powerful, pro-industry ways of thinking. Transparency ... can actually worsen the problem, because some people think simply disclosing a tie relieves any moral concern.”

Note: For lots more on this, see an informative article titled "The Statin Mafia Censors Pharmaceutical Harm." For more along these lines, see concise summaries of deeply revealing news articles on pharmaceutical industry corruption from reliable major media sources.

Three pharmaceutical companies collectively are agreeing to pay California nearly $70 million to settle allegations that they delayed drugs to keep prices high, California Attorney General Xavier Becerra said. The bulk of the money will come from Teva Pharmaceutical Industries Ltd. and its affiliates for paying to delay a generic narcolepsy drug, Provigil, from entering the market for nearly six years. Teva is paying $69 million, which Becerra says is the largest pay-for-delay settlement received by any state. Such agreements let the developer of brand name drugs keep their monopolies over the drugs after their patents expire, thereby letting them continue to charge consumers higher prices. The drug developer pays the generic manufacturer to keep the cheaper version of the drug from entering the marketplace for an agreed period of time. Such agreements can force consumers and the health care market to pay as much as 90% more than if there were generic alternatives. More than $25 million of the settlement will go to a consumer fund for California residents who purchased Provigil, Nuvigil or Modafinil between 2006 and 2012. The second, $760,000 settlement is with Teva, Endo Pharmaceuticals and Teikoku Pharma USA over keeping a genetic alternative to the pain patch Lidoderm from entering the market for nearly two years. Both settlements bar the companies from pay-for-delay agreements for several years.

Note: They are only barred from pay-for-delay agreements for several years? Shouldn't this practice be illegal? For more along these lines, see concise summaries of deeply revealing news articles on pharmaceutical industry corruption from reliable major media sources.

A northwest Indiana dairy farm has fired four employees seen in a graphic undercover video released Tuesday by an animal welfare organization showing animals being abused. Following an investigation into the abuse, at least three retailers announced Wednesday that they would remove all Fairlife products from their shelves. The Coca Cola Corporation, which distributes the brand, said it was in talks to have sourcing from the farm in question discontinued. The Animal Recovery Mission called it the “largest undercover dairy investigation in history” and said the video documents “systemic and illegal abuse” at Fair Oaks Farms in Indiana. ARM said an investigator spent three months undercover at the Prairies Edge North Barn after being hired as a calf care employee. The group noted that Fair Oaks Farms North Barn was not targeted, but rather the barn was the first farm to hire the investigator, who had applied to multiple dairy farms in Jasper and Newton Counties in Indiana. “Employees were observed slapping, kicking, punching, pushing, throwing and slamming calves,” ARM said in a statement. “Calves were stabbed and beaten with steel rebars, hit in the mouth and face with hard plastic milking bottles, kneed in the spine, burned in the face with hot branding irons, subjected to extreme temperatures, provided with improper nutrition, and denied medical attention.” The footage was released on social media (warning: footage is graphic) Tuesday, where it has since garnered more than 100,000 views on Facebook and more than 1 million views on Vimeo.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corruption in the food industry from reliable major media sources.

Carbon credit speculators could lose billions as scientific evidence shows many offsets they have bought have no environmental worth and have become stranded assets. Amid growing evidence that huge numbers of carbon credits do nothing to mitigate global heating and can sometimes be linked to alleged human rights concerns, there is a growing pile of carbon credits ... that are unused in the unregulated voluntary market, according to market analysis. Many of the largest companies in the world have used carbon credits for their sustainability efforts from the unregulated voluntary market, which grew to $2bn (Ł1.6bn) in size in 2021 and saw prices for many carbon credits rise above $20 per offset. The credits are often generated on the basis they are contributing to climate change mitigation such as stopping tropical deforestation, tree planting and creating renewable energy projects. A new study in the journal Science has found that millions of forest carbon credits approved by Verra, the world's leading certifier, are largely worthless and could make global heating worse if used for offsetting. The analysis ... found that 18 big forest offsetting projects had produced millions of carbon credits based on calculations that greatly inflated their conservation impact. The schemes, which generate credits by avoiding hypothetical deforestation, were found not to reduce forest loss or to reduce it by only small amounts, far less than the huge areas they were claiming to protect, rendering the credits largely hot air.

Note: For more along these lines, see concise summaries of deeply revealing news articles on financial industry corruption and climate change from reliable major media sources.

On at least four occasions since 2019, Elon Musk has predicted that his medical device company, Neuralink, would soon start human trials of a revolutionary brain implant to treat intractable conditions such as paralysis and blindness. Yet the company, founded in 2016, didn't seek permission from the U.S. Food and Drug Administration (FDA) until early 2022 – and the agency rejected the application. Musk has detailed a bold vision for Neuralink: Both disabled and healthy people will pop into neighborhood facilities for speedy surgical insertions of devices with functions ranging from curing obesity, autism, depression or schizophrenia to web-surfing and telepathy. Musk also has said Neuralink would restore full mobility to paralyzed patients. Reuters exclusively reported late last year that the federal government was investigating the company's treatment of its research animals. The probe was launched amid growing employee concern that the company is rushing experiments, causing additional suffering and deaths of pigs, sheep and monkeys. Musk's company ... trails at least one direct rival in the race for FDA approval. Synchron, a competitor making a BCI implant, has won the agency's blessing for human trials. The company first tested its device on four patients in Australia who successfully sent text messages with their minds. Synchron recently raised $75 million, including from funds backed by tech billionaires Bill Gates and Jeff Bezos.

Note: For more along these lines, see concise summaries of deeply revealing news articles on microchip implants from reliable major media sources.

The world is spending at least $1.8tn (Ł1.3tn) every year on subsidies driving the annihilation of wildlife and a rise in global heating, according to a new study, prompting warnings that humanity is financing its own extinction. From tax breaks for beef production in the Amazon to financial support for unsustainable groundwater pumping in the Middle East, billions of pounds of government spending and other subsidies are harming the environment, says the first cross-sector assessment for more than a decade. This government support, equivalent to 2% of global GDP, is directly working against the goals of the Paris agreement and draft targets on reversing biodiversity loss, the research on explicit subsidies found, effectively financing water pollution, land subsidence and deforestation with state money. The fossil fuel industry ($620bn), the agricultural sector ($520bn), water ($320bn) and forestry ($155bn) account for the majority of the $1.8tn, according to the report. No estimate for mining, believed to cause billions of dollars of damage to ecosystems every year, could be derived. Lack of transparency between governments and recipients means the true figure is likely to be much higher, as is the implicit cost of harmful subsidies. Last year, an International Monetary Fund report found the fossil fuel industry benefited from subsidies worth $5.9tn in 2020.

Note: For more along these lines, see concise summaries of deeply revealing news articles on government corruption and climate change from reliable major media sources.

Members of the Sackler family who are at the center of the nation's deadly opioid crisis have won sweeping immunity from opioid lawsuits linked to their privately owned company Purdue Pharma and its OxyContin medication. Federal Judge Robert Drain approved a bankruptcy settlement on Wednesday that grants the Sacklers "global peace" from any liability for the opioid epidemic. "This is a bitter result," Drain said. "I believe that at least some of the Sackler parties have liability for those [opioid OxyContin] claims. ... I would have expected a higher settlement." The complex bankruptcy plan ... grants "releases" from liability for harm caused by OxyContin and other opioids to the Sacklers, hundreds of their associates, as well as their remaining empire of companies and trusts. In return, they have agreed to pay roughly $4.3 billion, while also forfeiting ownership of Purdue Pharma. The Sacklers, who admit no wrongdoing and who by their own reckoning earned more than $10 billion from opioid sales, will remain one of the wealthiest families in the world. Critics of this bankruptcy settlement, meanwhile, said they would challenge Drain's confirmation because of the liability releases for the Sacklers. "This order is insulting to victims of the opioid epidemic who had no voice in these proceedings," said Washington state Attorney General Bob Ferguson. The Department of Justice urged Drain to reject the settlement. Attorneys general for nine states and the District of Columbia also opposed the plan.

Note: Purdue Pharma spent $1.2 million on lobbying just before making this deal. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.

40 years ago, a worn-out white Gulfstream II jet descended over Fort Lauderdale, Fla., carrying a regal but sickly passenger almost no one was expecting. Aboard were a Republican political operative, a retinue of Iranian military officers ... and Mohammed Reza Pahlavi, the newly deposed shah of Iran. The only one waiting to receive the deposed monarch was a senior executive of Chase Manhattan Bank, which had not only lobbied the White House to admit the former shah but had arranged visas for his entourage. Less than two weeks later, on Nov. 4, 1979, vowing revenge for the admission of the shah to the United States, revolutionary Iranian students seized the American Embassy in Tehran and then held more than 50 Americans — and Washington — hostage for 444 days. The shah, Washington’s closest ally in the Persian Gulf, had fled Tehran in January 1979. The shah sought refuge in America. But President Jimmy Carter ... refused him entry for the first 10 months of his exile. Chase Manhattan Bank and its well-connected chairman worked behind the scenes to persuade the Carter administration to admit the shah, one of the bank’s most profitable clients. For Mr. Carter, for the United States and for the Middle East it was an incendiary decision. The ensuing hostage crisis enabled Ayatollah Ruhollah Khomeini to consolidate his theocratic rule, started a four-decade conflict between Washington and Tehran ... and helped Ronald Reagan take the White House.

Note: More information is available in this 1991 New York Times article and this article. For more along these lines, see concise summaries of deeply revealing news articles on government corruption from reliable major media sources.

When women speak, they shouldn’t be shrill. Clothing must flatter, but short skirts are a no-no. After all, “sexuality scrambles the mind.” Women should look healthy and fit, with a “good haircut” and “manicured nails.” These were just a few pieces of advice that around 30 female executives at Ernst & Young received at a training held in the accounting giant’s gleaming new office in Hoboken, New Jersey, in June 2018. The 55-page presentation, used during the day-and-a-half seminar on leadership and empowerment, was given to HuffPost by an attendee who was appalled by its contents. Full of out-of-touch advice, the presentation focused on how women need to fix themselves to fit into a male-dominated workplace. The training, called Power-Presence-Purpose or PPP ... was billed to participants as advice on how to be successful at EY, according to Jane, a training attendee and former executive director at the firm. Attendees were even told that women’s brains are 6% to 11% smaller than men’s, Jane said. She wasn’t sure why they were told this, nor is it clear from the presentation. Women’s brains absorb information like pancakes soak up syrup so it’s hard for them to focus, the attendees were told. Men’s brains are more like waffles. They’re better able to focus because the information collects in each little waffle square. The only reason to talk to women about their size of their brains is to make them feel inferior to men, said Bruce McEwen, a neuroscientist at Rockefeller University.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption from reliable major media sources.

About a half a dozen journalists were in a northern California courtroom to cover a third lawsuit alleging that Monsanto’s pesticide glyphosate causes cancer. [Sylvie] Barak told others that she was a freelancer for the BBC. When journalists searched the internet for Barak, they noticed that her LinkedIn account said she worked for FTI Consulting, a global business advisory firm that Monsanto and Bayer, Monsanto’s parent company, had engaged for consulting. Monsanto has also previously employed shadowy networks of consultants, PR firms, and front groups to spy on and influence reporters. And all of it appears to be part of a pattern at the company of using a variety of tactics to intimidate, mislead and discredit journalists and critics. In the latest example of Monsanto’s efforts to track journalists, The Guardian reported in August on internal documents from the company’s “fusion center,” which worked to discredit reporters and nonprofits via third-party actors. In the California trial, the reporter who first identified Barak as an FTI plant said she ... saw an uptick in Monsanto’s industry partners contacting her as she covered the trial. A guy named Jay Byrne ... contacted her on social media to discuss how GMO criticism was part of a Russian influence campaign; when she Googled Byrne, she learned he is Monsanto’s former director of communications. In a January deposition, a Monsanto representative said that in 2016 the company spent “around $16 or 17 million” on activities to defend glyphosate.

Note: Major lawsuits are now unfolding over Monsanto's lies to regulators and the public on the dangers of glyphosate. Yet the EPA continues to use industry studies to declare Roundup safe while ignoring independent scientists. For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption from reliable major media sources.

In 2015, Maryland’s main election system vendor was bought by a parent company with ties to a Russian oligarch. The state’s election officials did not know about the purchase until July 2018, when the FBI notified them of the potential conflict. The FBI investigated and did not find any evidence of tampering or sharing of voter data. But the incident was a giant red flag ... especially as many states have outsourced vote-counting to the private sector. Democracy in the United States is now largely a secretive and privately-run affair conducted out of the public eye with little oversight. The corporations that run every aspect of American elections, from voter registration to casting and counting votes by machine, are subject to limited state and federal regulation. The companies are privately-owned and closely held, making information about ownership and financial stability difficult to obtain. The software source code and hardware design of their systems are kept as trade secrets. A small network of companies ... have near-monopolies on election services, such as building voting machines. Across the spectrum, private vendors have long histories of errors that affected elections, of obstructing politicians and the public from seeking information, of corruption, suspect foreign influence, false statements of security and business dishonesty. The computer security world has been sounding the alarm since voting machines were adopted. Now lawmakers, election officials and national security experts are joining in.

Note: Computer scientists have shown nearly every make and model of electronic voting machine to be vulnerable to hacking. For more along these lines, see concise summaries of deeply revealing elections corruption news articles from reliable major media sources.

During a nine month investigation, the BBC has uncovered the disturbing truth about the way authorities in New York City are conducting the fight against Aids. HIV positive children - some only a few months old - are enrolled in toxic experiments without the consent of guardians or relatives. In some cases where parents have refused to give children their medication, they have been placed in care. The city's Administration of Children's Services (ACS) does not even require a court order to place HIV kids with foster parents or in children's homes, where they can continue to give them experimental drugs. In 2002, the Incarnation Children's Center - a children's home in Harlem - was at the hub of controversy over secretive drugs trials. [Reporter Jamie Doran] speaks to a boy who spent most of his life at Incaranation. Medical records, obtained by the This World team, prove the boy had been enrolled in these trials. "I did not want to take my medication," said the boy, "but if you want to get out of there, you have to do what they say." He also conveys a horrifying account of what happened to the children at Incarnation who refused to obey the rules. "My friend Daniel didn't like to take his medicine and he got a tube in his stomach," he said. For months, the BBC tried to get information from the people responsible for the trials, but none would comment. The companies that supply drugs for the trials are among the world's largest, including Britain's own Glaxo SmithKline (GSK).

Note: Read a long list of examples of humans being treated as guinea pigs by corporate and governmental programs. For more along these lines, see concise summaries of deeply revealing news articles on corruption in government and in Big Pharma from reliable major media sources.

When Megan Rothbauer suffered a heart attack at work in Wisconsin, she was rushed to hospital in an ambulance. The nearest hospital was "not in network", which left Ms Rothbauer with a $52,531.92 bill for her care. Had the ambulance driven a further three blocks to Meriter Hospital in Madison, the bill would have been a more modest $1,500. The incident laid bare the expensive complexity of the American healthcare system with patients finding that they are uncovered, despite paying hefty premiums, because of their policy's small print. In many cases the grounds for refusal hinge on whether the insurer accepts that the treatment is necessary and that decision is increasingly being made by artificial intelligence rather than a physician. It is leading to coverage being denied on an industrial scale. Much of the work is outsourced, with the biggest operator being EviCore, which ... uses AI to review – and in many cases turn down – doctors' requests for prior authorisation, guaranteeing to pay for treatment. The controversy over coverage denials was brought into sharp focus by the gunning down of UnitedHealthcare's chief executive Brian Thompson in Manhattan. The [words written on the] casings [of] the ammunition – "deny", "defend" and "depose" – are thought to refer to the tactics the insurance industry is accused of using to avoid paying out. UnitedHealthcare rejected one in three claims last year, about twice the industry average.

Note: For more along these lines, read our concise summaries of news articles on AI and corporate corruption.

Last week, I was on the path to publishing a piece in a major legacy media outlet–a name all of you would instantly recognize–about Trump's bold appointment of RFK Jr. as head of the Department of Health and Human Services (HHS). For weeks, I had been in discussions with an editor about publishing this article, which argued that Trump appears to be genuinely signalling toward transformative health policy reform. After submitting the piece late Tuesday night to meet a Wednesday deadline, I received a surprising email from my editor the following morning: "Appears we don't approve." She linked to a new editorial board piece labeling RFK Jr. a "fringe conspiracy theorist" likely to harm public health. Her follow-up message read, "We have come out aggressively against Kennedy." Just like that, my piece was axed. My commitment to honest reporting and ideological independence opened many doors. Until it didn't. I discovered that hot-button topics I tackled like identity politics and police brutality were actually far less contentious than the third rail of Big Pharma and government health policies. Wokism is a far less pernicious, gargantuan force in American politics and media than Pfizer, Merck, and Moderna. By 2021, as the pandemic and vaccine mandates became politically charged, my pitches began to hit a wall. Outlets that once published polarizing takes now resisted anything questioning mainstream pandemic narratives.

Note: This article was written by independent journalist Rav Arora. For more along these lines, read our concise summaries of news articles on censorship and media manipulation.

A federal jury held a defense contractor legally responsible for contributing to the abuse of detainees at Abu Ghraib for the first time. The jury awarded a total of $42 million to three Iraqi men – a journalist, a middle school principal, and fruit vendor – who were held at the notorious prison two decades ago. The plaintiffs' suit accused Virginia-based CACI, which was hired by the U.S. government to provide interrogation services at Abu Ghraib, of conspiring with American soldiers to torture detainees. CACI had argued that while abuses did occur at Abu Ghraib, it was ultimately the Army who was responsible for this conduct, even if CACI employees may have been involved. The defense contractor also argued there was no definitive evidence that their staff abused the three Iraqi men who filed the case – and that it could have been American soldiers who tortured them. The jury did not find that argument persuasive. The case was filed 16 years ago but got caught up in procedural hurdles, as CACI tried more than 20 times to dismiss the lawsuit. The plaintiffs – Suhail Najim Abdullah Al Shimari, Salah Hasan Nusaif Al-Ejaili, and Asa'ad Hamza Hanfoosh Zuba'e – had testified about facing sexual abuse and harassment, as well as being beaten and threatened with dogs at Abu Ghraib. "My body was like a machine, responding to all external orders," [said] Al-Ejaili, a former journalist with Al Jazeera. "The only part I owned was my brain."

Note: Read more about the horrors of Abu Ghraib. Learn more about US torture programs in our comprehensive Military-Intelligence Corruption Information Center. For more, see concise summaries of deeply revealing news articles on military corruption from reliable major media sources.

Important Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.